Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Hammersmith Hospitals NHS Trust.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Hammersmith Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT00246129
First received: October 28, 2005
Last updated: May 9, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2011
  Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)